HealthTech capital members serve for rotating terms on the Screening Committee. These members have experience with the HealthTech stakeholders including business solutions for providers, payers and patients. Our members’ expertise covers Digital Health, Pharmaceuticals & Therapeutics, Medical Device & Instrumentation, Drug Discoveries, Diagnostics and Healthcare Services.
Chairman Screening Committee
Prior to founding Metis Lighthouse, Carl served in leadership roles at Abbott and Guidant in general management, global marketing, new product development, and geography marketing. He has experience leading teams in Asia, Europe, Canada, and the United States. Prior to joining Guidant, Carl was a successful entrepreneur with a leading custom DNA, peptides, and genes startup. Carl holds a B.S. degree in biomedical science from Texas A&M University, and an MBA from INSEAD in France.
Do you charge companies to present?Absolutely not! HTC does not charge application or presentation fees. Because HealthTech Capital provides significant added value to companies, such as leading a term sheet, strategic advice, industry connections, mentoring, board members and board observers, common stock options are expected in exchange for these services.